Mechanism
IL-31, IL-4, and IL-36A
Assets acting on this target.
- Class
- topical multi-cytokine modulator ("Hexagen"), non-systemic upstream immunomodulator
- Pathway
- inhibits IL-31, IL-4, and IL-36A at the earliest upstream inflammatory events before chronic inflammation/itch/barrier breakdown becomes self-sustaining
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.